Product Information
METRONIDAZOLE 250 MG TABLET is a generic product labeled by Method Pharmaceuticals LLC, priced at $0.1007 per EA under NDC 58657093305. Its NADAC has been published 29 times since Dec 10, 2025.
Strength
250 mg/1
Manufacturer
Method Pharmaceuticals LLCNDC
58657093305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA070772On Market Since
7/1/2025
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 250 MG TABLET has been published 29 times since Dec 10, 2025, and over the history we have for it it has risen 38.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1007 per EA |
|---|---|
| All-time high | $0.1007 (Jun 24, 2026) |
| All-time low | $0.0623 (Dec 17, 2025) |
| 52-week high | $0.1007 |
| 52-week low | $0.0623 |
| Median price | $0.0713 |
| Average price | $0.0738 |
| Largest weekly change | +20.1% (Jun 17, 2026) |
| Weeks tracked | 29 |
| Tracking since | Dec 10, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by Method Pharmaceuticals LLC, is $0.1007 per EA (NDC 58657093305), effective Jun 24, 2026.
How has the price of METRONIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has risen 38.9%. It has been tracked across 29 weekly CMS publications since Dec 10, 2025.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?
Since Dec 10, 2025, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0623 (Dec 17, 2025) to a high of $0.1007 (Jun 24, 2026), with a median of $0.0713 per EA.
Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as METRONIDAZOLE 250 MG TABLET, but none are currently priced below it.
Who manufactures METRONIDAZOLE 250 MG TABLET?
METRONIDAZOLE 250 MG TABLET (NDC 58657093305) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification